RHYTHM PHARMACEUTICALS, INC. Operating Lease Liability
RHYTHM PHARMACEUTICALS, INC. (RYTM) had Operating Lease Liability of $4.03 million as of 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-11-06
- 2024-09-30: Operating Lease, Liability $4.03M.
- 2024-06-30: Operating Lease, Liability $4.12M.
- 2024-03-31: Operating Lease, Liability $1.08M.
- 2023-12-31: Operating Lease, Liability $1.26M.
| Period end | Operating Lease, Liability |
|---|---|
| 2024-09-30 | $4.03M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $4.12M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.08M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.26M 10-K · filed 2024-02-29 |
| 2023-09-30 | $1.44M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $1.61M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $1.78M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $1.94M 10-K · filed 2023-03-01 |
| 2022-09-30 | $2.10M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.26M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $2.41M 10-Q · filed 2022-05-03 |
| 2021-12-31 | $2.55M 10-K · filed 2022-03-01 |
| 2021-09-30 | $2.69M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $2.83M 10-Q · filed 2021-08-03 |
| 2021-03-31 | $2.96M 10-Q · filed 2021-05-03 |
| 2020-12-31 | $3.09M 10-K · filed 2021-03-01 |
| 2020-09-30 | $3.21M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $3.33M 10-Q · filed 2020-08-03 |
| 2020-03-31 | $3.45M 10-Q · filed 2020-05-04 |
| 2019-12-31 | $3.56M 10-K · filed 2020-03-02 |
| 2019-09-30 | $3.67M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $3.71M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $3.65M 10-Q · filed 2019-05-03 |
| 2019-01-01 | $3.64M 10-Q · filed 2020-11-02 |
| 2018-12-31 | $3.64M 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |